receive daily
reports of the
TOP PICKS
OR
your personal
stock choices
| Click Here to receive daily reports of the TOP PICKS OR your personal stock choices | STOCKCHASEWhat the experts are saying! |
|
| There are 11 registered members and 95 guests viewing the site. | Follow us on Twitter |  Rss Top Picks Feed | Rss Daily Feed |
|
| TOP PICK | 43.510 | Danny Tomka | Stock price has been cut in half since March/04 because of their depression drug which is coming off patent. Creating their own generic drug. Great company. Juggernaut sales force. Has about $4 of cash. Has a product ramp in alzheimers. | 2004-11-09 | |
| TOP PICK | 42.510 | John Sinkins, CFA | Had dropped because of concerns about teens using their anti-depressant. A good price. | 2004-09-13 | |
| BUY | 51.900 | Brian Milner | Buy, stick away and don't look at it for quite awhile. Costs are low on R & D because they tend to buy compounds that have already been researched. Not cheap. | 2003-05-02 |
